English | Français  

Home

Project Results

What is a Quality Measure?

Who is CEQM?

National Consensus

National Consensus Summary

Top 30 Quality Measures

Quality Measures Database

Priority Domains

Data Infrastructure

Measurement Implementation

Knowledge Transfer / Communication

Project Activities

Contact

Links



Staff/Partner log-in
  

Quality Measures Database

Detailed Results


Use checkboxes to select measures to print or display              
Screening Tool for Substance Problems Overall Rank: 63
Use of a common, validated screening tool (e.g., a four-item test with questions on Cutting down, Annoyance at criticism, Guilty feelings and use of Eye-openers (CAGE), The Alcohol Use Disorders Identification Test (AUDIT)) for alcohol or other drug problems for all new patients.
Diagnosis and initiation of treatment at very early stages of the disease, when little or minimum intervention can bring therapeutic results (e.g., within the first two years of illness).
Additional Domain(s) : Patients with Comorbid Conditions, Accessibility
Rationale
The medical literature does not support definitive statements about the best way(s) to treat patients who are diagnosed with both major depression and substance abuse/dependence. The majority of studies reviewed indicate that success in treating dependency on alcohol, cocaine, and other abused substances is more likely if accompanying depression is addressed. There is some evidence that patients with major depression which is secondary to their substance abuse may have remission if their depressed mood once the substance abuse is treated. However, it is difficult to separate secondary depression from primary depression that predates or is separate from the substance use.

The CAGE questions are sensitive and specific for diagnosing alcoholism. One positive response has a sensitivity if 85% and a specificity of 89%, and two positive responses has a specificity of 96%.
Primary Reference
Major Depression in Adults in Primary Care. May 2004, Institute for Clinical Systems Improvement. P: 12 Retrieved on Aug 3, 2006 From:http://www.icsi.org/knowledge/detail.asp?catID=29&itemID=180
Level of Evidence
III: Preliminary research evidence only or evidence based on consensus opinion only.

Summarized CommentsAdd Comment
  • * Not sure if this should be a requirement for all, but it certainly should, when situations would suggest a problem.
Variation in Results
Ratings-based Rank
Relevance 84
Actionability 23
Overall Importance 81
 
Stakeholder Rank
Academics 52
Clinicians 53
Consumers 75
Decision Makers 66
 
Special Group Rank
First Nations 70
Rural Areas 73
Federal Stakeholders 64
Regional Rank
BC AB SK MB ON QC NB NS PE NL YT NT NU
32 22 85 84 61 77 131 95 70 21 15 27 16
 
Overall Rank

      

63


SA15c (B570)

 
Distribution of Survey Respondent Ratings
Relevance
100
90
80
70
60
50
40
30
20
10
0
0 1.44 0.97 0.36 1.81 12.12 30.72 37.25 15.34
1 2 3 4 5 6 7 8 9
Low High
Actionability
100
90
80
70
60
50
40
30
20
10
0
0 1.87 0.54 0 2.52 10.3 28.56 42.43 13.78
1 2 3 4 5 6 7 8 9
Low High
Overall Importance
100
90
80
70
60
50
40
30
20
10
0
2.58 44.22 53.2
3 2 1

3 = can live without
2 = nice to have
1 = indispensable
Use checkboxes to select measures to print or display              

Copyright © 2006 CEQM and CARMHA • infoceqm-acmq.com

The views expressed herein do not necessarily represent the official policies of Health Canada